Israel Englander Uro Gen Pharma Ltd. Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, Millennium Management LLC holds 1,499,201 shares of URGN stock, worth $17.2 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,499,201

Previous 1,160,899 29.14%

Holding current value

$17.2 Million

Previous $19.5 Million 2.26%

% of portfolio

0.01%

Previous 0.01%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$12.7 - $17.92 $4.3 Million - $6.06 Million	338,302 Added 29.14%	1,499,201 $19 Million
Q2 2024 Aug 14, 2024	BUY	$12.72 - $19.2 $14.2 Million - $21.5 Million	1,119,019 Added 2671.97%	1,160,899 $19.5 Million
Q1 2024 May 15, 2024	SELL	$13.81 - $19.33 $5.31 Million - $7.43 Million	-384,626 Reduced 90.18%	41,880 $628,000
Q4 2023 Feb 14, 2024	BUY	$10.87 - $15.93 $2.55 Million - $3.73 Million	234,378 Added 121.99%	426,506 $6.4 Million
Q2 2023 Aug 14, 2023	SELL	$8.75 - $14.29 $1.42 Million - $2.32 Million	-162,648 Reduced 45.85%	192,128 $1.99 Million
Q1 2023 May 15, 2023	BUY	$7.99 - $11.02 $619,448 - $854,358	77,528 Added 27.96%	354,776 $3.28 Million
Q4 2022 Feb 14, 2023	SELL	$7.55 - $11.96 $1.23 Million - $1.94 Million	-162,274 Reduced 36.92%	277,248 $2.46 Million
Q3 2022 Nov 14, 2022	SELL	$7.21 - $9.41 $1.27 Million - $1.66 Million	-176,723 Reduced 28.68%	439,522 $3.66 Million
Q2 2022 Aug 15, 2022	BUY	$5.12 - $8.74 $2.35 Million - $4.01 Million	459,341 Added 292.75%	616,245 $5.05 Million
Q1 2022 May 16, 2022	BUY	$5.92 - $9.73 $529,319 - $869,978	89,412 Added 132.48%	156,904 $1.37 Million
Q4 2021 Feb 14, 2022	SELL	$9.03 - $19.13 $10,790 - $22,860	-1,195 Reduced 1.74%	67,492 $642,000
Q3 2021 Nov 15, 2021	BUY	$14.31 - $18.39 $69,932 - $89,871	4,887 Added 7.66%	68,687 $1.16 Million
Q2 2021 Aug 16, 2021	SELL	$15.2 - $20.94 $158,095 - $217,796	-10,401 Reduced 14.02%	63,800 $974,000
Q1 2021 May 17, 2021	BUY	$17.99 - $26.96 $48,195 - $72,225	2,679 Added 3.75%	74,201 $1.45 Million
Q4 2020 Feb 16, 2021	SELL	$17.54 - $25.43 $318,982 - $462,469	-18,186 Reduced 20.27%	71,522 $1.29 Million
Q3 2020 Nov 16, 2020	SELL	$18.81 - $26.42 $311,700 - $437,805	-16,571 Reduced 15.59%	89,708 $1.73 Million
Q2 2020 Aug 14, 2020	BUY	$16.5 - $29.7 $1.75 Million - $3.16 Million	106,279 New	106,279 $2.78 Million
Q4 2019 Feb 14, 2020	SELL	$21.11 - $34.86 $229,149 - $378,405	-10,855 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$23.83 - $36.44 $1.89 Million - $2.9 Million	-79,513 Reduced 87.99%	10,855 $258,000
Q2 2019 Aug 15, 2019	SELL	$32.75 - $40.35 $10.1 Million - $12.5 Million	-309,632 Reduced 77.41%	90,368 $3.25 Million
Q2 2019 Aug 14, 2019	BUY	$32.75 - $40.35 $9.83 Million - $12.1 Million	300,106 Added 300.42%	400,000 $4.14 Million
Q1 2019 May 14, 2019	SELL	$35.47 - $54.55 $354,629 - $545,390	-9,998 Reduced 9.1%	99,894 $3.69 Million
Q4 2018 Feb 14, 2019	SELL	$38.35 - $50.39 $4.73 Million - $6.22 Million	-123,461 Reduced 52.91%	109,892 $4.73 Million
Q3 2018 Nov 14, 2018	BUY	$41.65 - $51.7 $2.54 Million - $3.15 Million	61,021 Added 35.41%	233,353 $11 Million
Q2 2018 Aug 14, 2018	BUY	$48.35 - $65.33 $639,138 - $863,597	13,219 Added 8.31%	172,332 $8.58 Million
Q1 2018 May 15, 2018	BUY	$38.64 - $57.54 $5.7 Million - $8.49 Million	147,628 Added 1285.4%	159,113 $7.91 Million
Q4 2017 Feb 14, 2018	BUY	$27.28 - $43.26 $313,310 - $496,841	11,485	11,485 $427,000

Others Institutions Holding URGN

# of Institutions

130

Shares Held

35.9M

Call Options Held

22K

Put Options Held

93.8K

View Full List

About UroGen Pharma Ltd.

Ticker URGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 22,740,500
Market Cap $260M
Description
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...

More about URGN

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account